Warning: The NCBI web site requires JavaScript to function. more...

An official website of the United States government

Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Log in

Account

Logged in as:
username

Dashboard
Publications
Account settings
Log out

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

MeSH

NLM Controlled Vocabulary

Search database

Search term

Limits
Advanced
Help

Full

Format

Full
Full (text)
Summary
Summary (text)

Send to:

Choose Destination

File
Clipboard
Collections

Format

Oncolytic Virotherapy

Use of attenuated VIRUSES as ANTINEOPLASTIC AGENTS to selectively kill CANCER cells.

Year introduced: 2006

PubMed search builder options

adverse effects
classification
economics
ethics
history

instrumentation
methods
mortality
nursing
psychology

standards
statistics and numerical data
trends
veterinary

Restrict to MeSH Major Topic.

Do not include MeSH terms found below this term in the MeSH hierarchy.

Tree Number(s): E02.095.601

MeSH Unique ID: D050130

Entry Terms:

Oncolytic Virotherapies
Virotherapies, Oncolytic
Oncolytic Virus Therapy
Oncolytic Virus Therapies
Therapies, Oncolytic Virus
Therapy, Oncolytic Virus
Virus Therapies, Oncolytic
Virus Therapy, Oncolytic
Virotherapy, Oncolytic

See Also:

Oncolytic Viruses

All MeSH Categories

Analytical, Diagnostic and Therapeutic Techniques and Equipment Category

Biological Therapy

Oncolytic Virotherapy

Supplemental Content

Follow NCBI

Connect with NLM

National Library of Medicine
8600 Rockville Pike
Bethesda, MD 20894

Web Policies
FOIA
HHS Vulnerability Disclosure

Help
Accessibility
Careers

NLM
NIH
HHS
USA.gov